Anjos, Carolina dos 
; Sellera, Fábio Parra ; Ribeiro, Martha Simões ; Baptista, Maurício da Silva ; Pogliani, Fabio Celidonio ; Lincopan, Nilton ; Sabino, Caetano Padial
Fonte: Photodiagnosis and Photodynamic Therapy. Unidades: FMVZ, IQ, ICB, IPEN, FCF
Assuntos: TERAPIA FOTODINÂMICA, RESISTÊNCIA MICROBIANA ÀS DROGAS, BACTÉRIAS GRAM-NEGATIVAS, MICROBIOLOGIA, ANTIBIÓTICOS, AZUL DE METILENO, HIDRÓLISE, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANJOS, Carolina dos et al. Antimicrobial blue light and photodynamic therapy inhibit clinically relevant β-lactamases with extended-spectrum (ESBL) and carbapenemase activity. Photodiagnosis and Photodynamic Therapy, v. 32, p. 1-4 art. 102086, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.pdpdt.2020.102086. Acesso em: 06 nov. 2024.APA
Anjos, C. dos, Sellera, F. P., Ribeiro, M. S., Baptista, M. da S., Pogliani, F. C., Lincopan, N., & Sabino, C. P. (2020). Antimicrobial blue light and photodynamic therapy inhibit clinically relevant β-lactamases with extended-spectrum (ESBL) and carbapenemase activity. Photodiagnosis and Photodynamic Therapy, 32, 1-4 art. 102086. doi:10.1016/j.pdpdt.2020.102086NLM
Anjos C dos, Sellera FP, Ribeiro MS, Baptista M da S, Pogliani FC, Lincopan N, Sabino CP. Antimicrobial blue light and photodynamic therapy inhibit clinically relevant β-lactamases with extended-spectrum (ESBL) and carbapenemase activity [Internet]. Photodiagnosis and Photodynamic Therapy. 2020 ; 32 1-4 art. 102086.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.pdpdt.2020.102086Vancouver
Anjos C dos, Sellera FP, Ribeiro MS, Baptista M da S, Pogliani FC, Lincopan N, Sabino CP. Antimicrobial blue light and photodynamic therapy inhibit clinically relevant β-lactamases with extended-spectrum (ESBL) and carbapenemase activity [Internet]. Photodiagnosis and Photodynamic Therapy. 2020 ; 32 1-4 art. 102086.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.pdpdt.2020.102086
